awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34309227-21737DE2-31A5-42BE-8215-0FE524DA57D3
Q34309227-21737DE2-31A5-42BE-8215-0FE524DA57D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34309227-21737DE2-31A5-42BE-8215-0FE524DA57D3
Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer.
P2860
Q34309227-21737DE2-31A5-42BE-8215-0FE524DA57D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34309227-21737DE2-31A5-42BE-8215-0FE524DA57D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80b669d6c34ce6e2c6a0c69ca4195cbf13099f44
P2860
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.